Result of AGM

Resolution	Total votes for⁽¹⁾⁽²⁾	%	Total votes against⁽²⁾	%	Total votes cast	% of Issued Share Capital voted⁽³⁾	Votes withheld⁽⁴⁾
1	Receive and adopt the 2025 Annual Report	3,073,839,952	99.25	23,182,191	0.75	3,097,022,143	76.38%	8,652,004
2	Approve the Annual report on remuneration	2,986,046,185	96.74	100,644,457	3.26	3,086,690,642	76.12%	18,986,231
3	Approve the Remuneration policy	3,066,582,993	98.96	32,182,945	1.04	3,098,765,938	76.42%	6,914,570
4	Election of Luke Miels	3,081,325,569	99.37	19,501,818	0.63	3,100,827,387	76.47%	4,845,132
5	Re-election of Sir Jonathan Symonds	3,079,744,123	99.32	21,127,306	0.68	3,100,871,429	76.47%	4,793,341
6	Re-election of Julie Brown	3,069,722,312	99.00	31,102,814	1.00	3,100,825,126	76.47%	4,848,203
7	Re-election of Elizabeth McKee Anderson	3,042,023,812	98.52	45,732,363	1.48	3,087,756,175	76.15%	17,906,882
8	Re-election of Charles Bancroft	3,070,002,110	99.43	17,646,639	0.57	3,087,648,749	76.15%	18,018,954
9	Re-election of Dr Hal Barron	3,080,985,163	99.37	19,595,495	0.63	3,100,580,658	76.47%	5,088,510
10	Re-election of Dr Anne Beal	3,048,091,490	98.71	39,715,257	1.29	3,087,806,747	76.15%	17,858,160
11	Re-election of Wendy Becker	3,031,625,476	98.18	56,091,438	1.82	3,087,716,914	76.15%	17,946,122
12	Re-election of Dr Harry C Dietz	3,094,560,703	99.80	6,160,152	0.20	3,100,720,855	76.47%	4,943,572
13	Re-election of Dr Jeannie Lee	3,095,593,233	99.84	5,084,831	0.16	3,100,678,064	76.47%	4,985,598
14	Re-election of Dr Gavin Screaton	3,095,403,626	99.83	5,240,337	0.17	3,100,643,963	76.47%	5,019,966
15	Re-election of Dr Vishal Sikka	3,095,036,695	99.82	5,513,088	0.18	3,100,549,783	76.47%	5,111,280
16	Re-appointment of the auditor	3,099,113,772	99.94	1,891,083	0.06	3,101,004,855	76.48%	4,664,323
17	Remuneration of the auditor	3,098,976,181	99.94	1,736,335	0.06	3,100,712,516	76.47%	4,949,197
18	Authority for the company to make donations to political organisations and incur political expenditure	3,039,847,574	98.91	33,534,985	1.09	3,073,382,559	75.80%	32,288,122
19	Authority to allot shares	2,999,108,776	96.74	100,960,760	3.26	3,100,069,536	76.45%	5,592,295
20	Disapplication of pre-emption rights - general power⁽⁵⁾	3,046,584,734	98.32	51,962,919	1.68	3,098,547,653	76.42%	7,072,535
21	Disapplication of pre-emption rights - in connection with an acquisition or specified capital investment⁽⁵⁾	3,059,992,748	98.75	38,710,772	1.25	3,098,703,520	76.42%	6,947,940
22	Authority for the company to purchase its own shares⁽⁵⁾	3,093,867,095	99.82	5,669,416	0.18	3,099,536,511	76.44%	6,127,609
23	Exemption from statement of senior statutory auditor's name	3,079,861,236	99.81	5,739,421	0.19	3,085,600,657	76.10%	20,038,163
24	Authority for reduced notice of a general meeting other than an AGM⁽⁵⁾	2,911,856,203	93.98	186,503,587	6.02	3,098,359,790	76.41%	7,285,017
25	Approve the amended Articles of Association⁽⁵⁾	3,065,959,469	99.40	18,375,929	0.60	3,084,335,398	76.07%	21,304,284

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.

Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy

To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.

	GSK's 26^th AGM (Hybrid meeting) (2026)	GSK's 25^th AGM (Hybrid meeting) (2025)
Issued share capital (excluding Treasury Shares)	4,054,826,603	4,109,037,095
Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)	76.59%	74.21%
Total shareholder population	55,305	57,405
Total number of proxies lodged	2,475	2,617
Number of shareholders in attendance	117 in person 17 participated virtually	130 in person 25 participated virtually
% of shareholders who lodged proxies	4.48%	4.56%

Summary by AI ^BETAClose X

Companies

UK 100

Latest directors dealings

Result of AGM

Summary by AI BETAClose X

Companies

UK 100

Latest directors dealings

Summary by AI ^BETAClose X